Companies

Dec 9: LARS SORENSEN on emerging markets

In the first part of this week's View from the Top, Lars Sorensen, chief executive of Novo Nordisk, Denmark's biggest company, says the insulin producer will grow by 20 per cent a year in emerging markets.